US$ 20.13
glp 1 bcbs GLP-1 The #1 mistake on GLP-1s?
Description
"Weight regain after stopping treatment may affect the long-term sustainability of the observed benefits
Immediate reactions from the pharma industry reflected sentiment that the plan will not come to fruition, largely due to expected legal challenges

New delivery methods like GLP-1 patches and oral versus injectable formulations are also changing how these medications reach patients, which could indirectly affect eligibility standards as access models evolve
At the White House later Monday, Trump claimed drug prices would be reduced by 50% to 90%
